Selected research
Industry Growth & Trends
Global Diabetic Retinopathy Screening Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Diabetic Retinopathy Screening Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Diabetic Retinopathy Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Diabetic Retinopathy Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diabetic Retinopathy Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Diabetic Retinopathy Screening Software market include Retmarker, Retina Labs, Eyenuk, Inc., RetinaLyze, Intelligent Retinal Imaging Systems(IRIS), Retina AI, Optomed, RetinaRisk and InHealth Intelligence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Diabetic Retinopathy Screening Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Diabetic Retinopathy Screening Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetic Retinopathy Screening Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetic Retinopathy Screening Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Diabetic Retinopathy Screening Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Diabetic Retinopathy Screening Software Market by Company
Retmarker
Retina Labs
Eyenuk, Inc.
RetinaLyze
Intelligent Retinal Imaging Systems(IRIS)
Retina AI
Optomed
RetinaRisk
InHealth Intelligence
CSIRO
NEC Care
Diabetic Retinopathy Screening Software Segment by Type
Cloud Based
On-Premise
Diabetic Retinopathy Screening Software Segment by Application
Hospital Eye Diagnosis
Personal Screening
Medical Research
Diabetic Retinopathy Screening Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Diabetic Retinopathy Screening Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On-Premise
Applications
- Hospital Eye Diagnosis
- Personal Screening
- Medical Research
Companies covered
- Retmarker
- Retina Labs
- Eyenuk, Inc.
- RetinaLyze
- Intelligent Retinal Imaging Systems(IRIS)
- Retina AI
- Optomed
- RetinaRisk
- InHealth Intelligence
- CSIRO
- NEC Care
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Diabetic Retinopathy Screening Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Diabetic Retinopathy Screening Software Market Size by Region (2021-2032)
- 1.4.1 Global Diabetic Retinopathy Screening Software Market Size by Region (2021-2026)
- 1.4.2 Global Diabetic Retinopathy Screening Software Market Size by Region (2027-2032)
- 1.5 Key Regions Diabetic Retinopathy Screening Software Market Size (2021-2032)
- 1.5.1 North America Diabetic Retinopathy Screening Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Diabetic Retinopathy Screening Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Diabetic Retinopathy Screening Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Diabetic Retinopathy Screening Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Diabetic Retinopathy Screening Software Market Size Growth Rate (2021-2032)
2 Diabetic Retinopathy Screening Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Cloud Based
- 2.1.2 On-Premise
- 2.2 Global Diabetic Retinopathy Screening Software Market Size by Type
- 2.2.1 Global Diabetic Retinopathy Screening Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Diabetic Retinopathy Screening Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Diabetic Retinopathy Screening Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Diabetic Retinopathy Screening Software Market Size by Regions
- 2.3.1 North America Diabetic Retinopathy Screening Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Diabetic Retinopathy Screening Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Diabetic Retinopathy Screening Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Diabetic Retinopathy Screening Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Diabetic Retinopathy Screening Software Market Size Breakdown by Type (2021-2026)
3 Diabetic Retinopathy Screening Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital Eye Diagnosis
- 3.1.2 Personal Screening
- 3.1.3 Medical Research
- 3.2 Global Diabetic Retinopathy Screening Software Market Size by Application
- 3.2.1 Global Diabetic Retinopathy Screening Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Diabetic Retinopathy Screening Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Diabetic Retinopathy Screening Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Diabetic Retinopathy Screening Software Market Size by Regions
- 3.3.1 North America Diabetic Retinopathy Screening Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Diabetic Retinopathy Screening Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Diabetic Retinopathy Screening Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Diabetic Retinopathy Screening Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Diabetic Retinopathy Screening Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Diabetic Retinopathy Screening Software Industry Trends
- 4.2 Diabetic Retinopathy Screening Software Industry Drivers
- 4.3 Diabetic Retinopathy Screening Software Industry Opportunities and Challenges
- 4.4 Diabetic Retinopathy Screening Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Diabetic Retinopathy Screening Software Revenue (2021-2026)
- 5.2 Global Diabetic Retinopathy Screening Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Diabetic Retinopathy Screening Software Key Company Headquarters & Area Served
- 5.4 Global Diabetic Retinopathy Screening Software Company, Product Type & Application
- 5.5 Global Diabetic Retinopathy Screening Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Diabetic Retinopathy Screening Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Diabetic Retinopathy Screening Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Diabetic Retinopathy Screening Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Retmarker
- 6.1.1 Retmarker Company Information
- 6.1.2 Retmarker Business Overview
- 6.1.3 Retmarker Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Retmarker Diabetic Retinopathy Screening Software Product Portfolio
- 6.1.5 Retmarker Recent Developments
- 6.2 Retina Labs
- 6.2.1 Retina Labs Company Information
- 6.2.2 Retina Labs Business Overview
- 6.2.3 Retina Labs Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Retina Labs Diabetic Retinopathy Screening Software Product Portfolio
- 6.2.5 Retina Labs Recent Developments
- 6.3 Eyenuk, Inc.
- 6.3.1 Eyenuk, Inc. Company Information
- 6.3.2 Eyenuk, Inc. Business Overview
- 6.3.3 Eyenuk, Inc. Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eyenuk, Inc. Diabetic Retinopathy Screening Software Product Portfolio
- 6.3.5 Eyenuk, Inc. Recent Developments
- 6.4 RetinaLyze
- 6.4.1 RetinaLyze Company Information
- 6.4.2 RetinaLyze Business Overview
- 6.4.3 RetinaLyze Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 RetinaLyze Diabetic Retinopathy Screening Software Product Portfolio
- 6.4.5 RetinaLyze Recent Developments
- 6.5 Intelligent Retinal Imaging Systems(IRIS)
- 6.5.1 Intelligent Retinal Imaging Systems(IRIS) Company Information
- 6.5.2 Intelligent Retinal Imaging Systems(IRIS) Business Overview
- 6.5.3 Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Product Portfolio
- 6.5.5 Intelligent Retinal Imaging Systems(IRIS) Recent Developments
- 6.6 Retina AI
- 6.6.1 Retina AI Company Information
- 6.6.2 Retina AI Business Overview
- 6.6.3 Retina AI Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Retina AI Diabetic Retinopathy Screening Software Product Portfolio
- 6.6.5 Retina AI Recent Developments
- 6.7 Optomed
- 6.7.1 Optomed Company Information
- 6.7.2 Optomed Business Overview
- 6.7.3 Optomed Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Optomed Diabetic Retinopathy Screening Software Product Portfolio
- 6.7.5 Optomed Recent Developments
- 6.8 RetinaRisk
- 6.8.1 RetinaRisk Company Information
- 6.8.2 RetinaRisk Business Overview
- 6.8.3 RetinaRisk Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 RetinaRisk Diabetic Retinopathy Screening Software Product Portfolio
- 6.8.5 RetinaRisk Recent Developments
- 6.9 InHealth Intelligence
- 6.9.1 InHealth Intelligence Company Information
- 6.9.2 InHealth Intelligence Business Overview
- 6.9.3 InHealth Intelligence Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 InHealth Intelligence Diabetic Retinopathy Screening Software Product Portfolio
- 6.9.5 InHealth Intelligence Recent Developments
- 6.10 CSIRO
- 6.10.1 CSIRO Company Information
- 6.10.2 CSIRO Business Overview
- 6.10.3 CSIRO Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CSIRO Diabetic Retinopathy Screening Software Product Portfolio
- 6.10.5 CSIRO Recent Developments
- 6.11 NEC Care
- 6.11.1 NEC Care Company Information
- 6.11.2 NEC Care Business Overview
- 6.11.3 NEC Care Diabetic Retinopathy Screening Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 NEC Care Diabetic Retinopathy Screening Software Product Portfolio
- 6.11.5 NEC Care Recent Developments
7 North America
- 7.1 North America Diabetic Retinopathy Screening Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 7.3 North America Diabetic Retinopathy Screening Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Diabetic Retinopathy Screening Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 8.3 Europe Diabetic Retinopathy Screening Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Diabetic Retinopathy Screening Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Diabetic Retinopathy Screening Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Diabetic Retinopathy Screening Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 10.3 South America Diabetic Retinopathy Screening Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Diabetic Retinopathy Screening Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Diabetic Retinopathy Screening Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst